Related Experiment Video
Updated: Apr 15, 2026

Fluorescence detection methods for microfluidic droplet platforms
Published on: December 10, 2011
Portable microfluidic integrated plasmonic platform for pathogen detection
Onur Tokel1, Umit Hakan Yildiz2, Fatih Inci2
1Demirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Center for Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Abstract:
Timely detection of infectious agents is critical in early diagnosis and treatment of infectious diseases. Conventional pathogen detection methods, such as enzyme linked immunosorbent assay (ELISA), culturing or polymerase chain reaction (PCR) require long assay times, and complex and expensive instruments, which are not adaptable to point-of-care (POC) needs at resource-constrained as well as primary care settings. Therefore, there is an unmet need to develop simple, rapid, and accurate methods for detection of pathogens at the POC. Here, we present a portable, multiplex, inexpensive microfluidic-integrated surface plasmon resonance (SPR) platform that detects and quantifies bacteria, i.e., Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) rapidly. The platform presented reliable capture and detection of E. coli at concentrations ranging from ~10(5) to 3.2 × 10(7) CFUs/mL in phosphate buffered saline (PBS) and peritoneal dialysis (PD) fluid. The multiplexing and specificity capability of the platform was also tested with S. aureus samples. The presented platform technology could potentially be applicable to capture and detect other pathogens at the POC and primary care settings.
Insights
A new portable microfluidic-integrated surface plasmon resonance (SPR) platform offers rapid detection of bacteria like Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) at the point-of-care (POC). This inexpensive technology addresses the need for faster infectious disease diagnosis in resource-limited settings.
Area of Science:
- Biomedical Engineering
- Microfluidics
- Biosensing
Background:
- Timely detection of infectious agents is crucial for effective disease diagnosis and treatment.
- Conventional methods (ELISA, culturing, PCR) are time-consuming, expensive, and unsuitable for point-of-care (POC) applications.
- A need exists for rapid, simple, and accurate pathogen detection methods for POC settings.
Purpose of the Study:
- To develop a portable, multiplex, and inexpensive microfluidic-integrated surface plasmon resonance (SPR) platform.
- To enable rapid detection and quantification of bacterial pathogens at the POC.
Main Methods:
- Development of a microfluidic-integrated SPR platform.
- Testing the platform's ability to capture and detect Escherichia coli (E. coli) in phosphate-buffered saline (PBS) and peritoneal dialysis (PD) fluid.
- Evaluating the platform's multiplexing and specificity for Staphylococcus aureus (S. aureus).
Main Results:
- The platform demonstrated reliable capture and detection of E. coli across a concentration range of approximately 10^5 to 3.2 × 10^7 Colony Forming Units (CFUs)/mL.
- Successful testing of multiplexing and specificity capabilities with S. aureus samples.
- The platform achieved rapid detection of target bacteria.
Conclusions:
- The developed SPR platform is a promising technology for rapid, multiplexed bacterial detection at the POC.
- This technology can be adapted for detecting other pathogens in primary care and resource-constrained settings.
- It addresses the unmet need for accessible and efficient infectious disease diagnostics.
More Related Videos
13:42Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Published on: September 19, 2017
11:54Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles
Published on: March 13, 2017